Comparative genome‐wide profiling of post‐transplant lymphoproliferative disorders and diffuse large B‐cell lymphomas

Andrea Rinaldi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Francesco Bertoni(Ente Ospedaliero Cantonale), Maurilio Ponzoni(San Raffaele University of Rome), Afua A. Mensah(Institute of Oncology Research), Daniela Capello(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Giulia Poretti(Institute of Oncology Research), Giancarlo Pruneri(University of Milan), Ivo Kwee(Dalle Molle Institute for Artificial Intelligence Research), Carlo V. Catapano(Institute of Oncology Research), Emanuele Zucca(Università della Svizzera italiana), Marco Paulli(University of Milan), Maria Grazia Tibiletti(University of Insubria), Davide Rossi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
British Journal of Haematology
May 12, 2006
10.1111/j.1365-2141.2006.06114.x
Cited by 61

Related Papers

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665